CYRX: Revenue grew 14%, adjusted EBITDA turned positive, and 2026 guidance rose

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Q3 revenue rose 14% YoY to $50.2 million, with commercial CGT revenue up 20% and adjusted EBITDA positive at $1.1 million. Full-year 2026 revenue guidance increased to $197 million–$199 million.

Original document: CryoPort, Inc. [CYRX] SEC 8-K Current Report — Nov. 5 2026

Disclaimer
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Source: Quartr The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.